MAI Capital Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,000
| Closed | -$6.4K | – | 3342 |
|
|
2024
Q3 | $6.4K | Hold |
20,000
| – | – | ﹤0.01% | 1038 |
|
|
2024
Q2 | $8.54K | Hold |
20,000
| – | – | ﹤0.01% | 1193 |
|
|
2024
Q1 | $10.4K | Hold |
20,000
| – | – | ﹤0.01% | 1162 |
|
|
2023
Q4 | $14K | Hold |
20,000
| – | – | ﹤0.01% | 1059 |
|
|
2023
Q3 | $18.2K | Hold |
20,000
| – | – | ﹤0.01% | 1002 |
|
|
2023
Q2 | $11.4K | Hold |
20,000
| – | – | ﹤0.01% | 1009 |
|
|
2023
Q1 | $12.5K | Hold |
20,000
| – | – | ﹤0.01% | 999 |
|
|
2022
Q4 | $15.7K | Buy |
+20,000
| New | +$15.7K | ﹤0.01% | 959 |
|